July 13, 2007
It’s fairly clear that nanotechnology is no longer the new new thing. A recent story in Business Week - Nanotech Disappoints in Europe - is not atypical. It takes its lead from the recent difficulties of the UK nanotech company Oxonica, which it describes as emblematic of the nanotechnology sector as a whole: “a story of early promise, huge hype, and dashed hopes.” Meanwhile, in the slightly neophilic world of the think-tanks, one detects the onset of a certain boredom with the subject. For example, Jack Stilgoe writes on the Demos blog “We have had huge fun running around in the nanoworld for the last three years. But there is a sense that, as the term ‘nanotechnology’ becomes less and less useful for describing the diversity of science that is being done, interesting challenges lie elsewhere… But where?”
Source: Soft Machines.
No Comments » |
Biotechnology, Nanotechnology |
Permalink
Posted by olepetergalaasen
July 11, 2007
Scientists have engineered viruses to attack and destroy mega-colonies of potentially harmful bacteria called biofilms.
The work is one of the latest potential applications to emerge from synthetic biology, a burgeoning field that aims to change the genomes of organisms on large scales to make them more useful to humans or to even craft new life forms from scratch.
Source: Live Science.
No Comments » |
Biotechnology |
Permalink
Posted by olepetergalaasen
July 1, 2007

Two days from now I’m planning to further tweak my mind by taking a brain-boost pill. Called Provigil, it differs from its predecessors in that it is believed to home in on a section of the brain that helps govern alertness and memory. The pill is manufactured by Cephalon of Frazer, PA, and its active ingredient is called modafinil. The drug’s targeted delivery is supposed to prevent the side effects of stimulants that diffuse throughout the brain and rev up everything.
Source: Technology Review. See also “Climbing Walls with Carbon Nanotubes”.
No Comments » |
Biotechnology, Nanotechnology |
Permalink
Posted by olepetergalaasen
June 28, 2007
Call it bacterial alchemy: using a “genome transplant”, researchers have turned one species of bacterium into another. The transformation is the latest feat from US genomics pioneer Craig Venter, and marks another step towards his goal of creating a synthetic life-form.
Read the entire article at New Scientist.
See also “Blood cells can raft nanoparticles around the body”, New Scientist.
No Comments » |
Biotechnology, Nanotechnology |
Permalink
Posted by olepetergalaasen
June 18, 2007
The ultimate goal of nanomedicine is to perform nanorobotic therapeutic procedures on specified individual cells comprising the human body. This paper reports the first theoretical scaling analysis and mission design for a cell repair nanorobot. One conceptually simple form of basic cell repair is chromosome replacement therapy (CRT), in which the entire chromatin content of the nucleus in a living cell is extracted and promptly replaced with a new set of prefabricated chromosomes which have been artificially manufactured as defect-free copies of the originals.
Read the entire article at Journal of Evolution and Technology.
See also the “Singularity Warfare: A Bibliometric Survey of Militarized Transhumanism“
No Comments » |
Biotechnology, Nanotechnology |
Permalink
Posted by olepetergalaasen